Carprox vet 50 mg/ml solution for injection for dogs and cats

Страна: Ирландия

Език: английски

Източник: HPRA (Health Products Regulatory Authority)

Активна съставка:

Carprofen

Предлага се от:

Krka, d.d., Novo mesto

АТС код:

QM01AE91

INN (Международно Name):

Carprofen

дозиране:

50 milligram(s)/millilitre

Лекарствена форма:

Solution for injection

Вид предписание :

POM: Prescription Only Medicine as defined in relevant national legislation

Терапевтична група:

Cats, Dogs

Терапевтична област:

carprofen

Терапевтични показания:

N.S.A.I.D.

Статус Оторизация:

Authorised

Дата Оторизация:

2010-12-10

Данни за продукта

Health Products Regulatory Authority
02 October 2020
CRN009W8M
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Carprox vet 50 mg/ml solution for injection for dogs and cats
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCE:
Carprofen
50 mg
EXCIPIENT:
Benzyl alcohol (E1519)
10 mg
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Solution for injection.
Clear, pale yellow coloured solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs and cats.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Dogs: For the control of post-operative pain and inflammation
following orthopaedic and soft tissue (including intraocular)
surgery.
Cats: For the control of post-operative pain following surgery.
4.3 CONTRAINDICATIONS
Do not use in animals suffering from cardiac, hepatic or renal disease
or gastrointestinal problems, where there is a possibility
of gastrointestinal ulceration or bleeding, or hypersensitivity to
carprofen or any other NSAIDs or any excipients of this product.
As with other NSAIDs there is a risk of rare renal or idiosyncratic
hepatic adverse events.
Do not administer by intramuscular injection.
Do not use after surgery which was associated with considerable blood
loss.
Do not use in cats on repeated occasions.
Do not use in cats less than 5 months of age.
Do not use in dogs less than 10 weeks of age.
See also section 4.7.
Health Products Regulatory Authority
02 October 2020
CRN009W8M
Page 2 of 4
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Due to the longer half life in cats and narrower therapeutic index,
particular care should be taken not to exceed the
recommended dose and the use of a 1 ml graduated syringe is
recommended to measure the dose accurately.
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Do not exceed the recommended dose or duration of treatment.
Due to the longer half life in cats and narrower therapeutic index,
particular care should be taken not to exceed the
recommend